Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins

Autor: Wu, C-AM, Roth, TL, Baglaenko, Y, Ferri, DM, Brauer, P, Zuniga-Pflucker, JC, Rosbe, KW, Wither, JE, Marson, A, Allen, CDC

Publikováno v: Wu, C-AM; Roth, TL; Baglaenko, Y; Ferri, DM; Brauer, P; Zuniga-Pflucker, JC; et al.(2018). Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins. JOURNAL OF IMMUNOLOGICAL METHODS, 457, 33-40. doi: 10.1016/j.jim.2018.03.009. UCSF: Retrieved from: http://www.escholarship.org/uc/item/8tz7f0xm

Genome editing in human cells with targeted nucleases now enables diverse experimental and therapeutic genome engineering applications, but extension to primary human B cells remains limited. Here we report a method for targeted genetic engineering i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1502d67738387711940f9ac6b89dcce6
https://escholarship.org/uc/item/8tz7f0xm

Suppression of sheep and goat lymphocyte proliferation by sheep, goat, and sheep × goat hybrid trophoblast tissue cultures

Autor: Roth Tl, Kenneth L. White, D. W. Horohov

Publikováno v: Journal of Animal Science. 69:4563-4569

Immunosuppressive activity of conditioned medium from cultured ovine, caprine, and hybrid trophoblast tissue was examined. Conceptuses were obtained from naturally mated donor ewes and does at d 20 of gestation and trophoblast tissue was cultured for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c13da898fca41d97929b52ce0eaf5a
https://doi.org/10.2527/1991.69114563x

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.